Latest News
Data from Partner Therapeutics' eNRGy trial of zenocutuzumab published in Journal of Clinical Oncology
3 July 2026 - Integrated biotechnology company Partner Therapeutics Inc (PTx) reported on Thursday that results from the cholangiocarcinoma cohort of the eNRGy trial have been published in the Journal of Clinical Oncology (JCO).According to PTx, the ...
Arcturus Therapeutics and Thermo Fisher enter strategic collaboration on ARCT-032 development
2 July 2026 - Messenger RNA medicines company Arcturus Therapeutics Holdings Inc (Nasdaq:ARCT) announced on Thursday that it has entered into a strategic collaboration with Thermo Fisher Scientific Inc (NYSE:TMO) to support Phase 3 development and po...
United Therapeutics acquires Thymmune Therapeutics to expand regenerative cell therapy pipeline
2 July 2026 - Biotechnology company United Therapeutics Corporation (Nasdaq:UTHR) announced on Thursday that it has acquired Thymmune Therapeutics, a privately held, preclinical stage biotechnology company focused on regenerative thymic cell therapie...
Genentech reports positive Phase III results for divarasib in KRAS G12C lung cancer
2 July 2026 - Biotechnology company Genentech, a member of the Roche Group (SIX: RO, ROG) (OTCQX: RHHBY), on Thursday reported positive Phase III results from the Krascendo 1 trial evaluating investigational KRAS G12C inhibitor divarasib in patients ...
Alligator Bioscience reports first patient dosed in early-stage breast cancer study
2 July 2026 - Swedish biotechnology company Alligator Bioscience AB (STO:ATORX) reported on Thursday that the first patient has been dosed in an investigator-initiated trial evaluating intratumoural administration of its lead CD40 agonist, mitazalima...